Skip to main content

Table 6 Univariate and multivariate Cox analysis of OS among patients who received EGFR-TKI treatment

From: Effects of reduced platelet count on the prognosis for patients with non-small cell lung cancer treated with EGFR-TKI: a retrospective study

  Univariate analysis Multivariate analysis
HR 95%CI P HR 95%CI P
Platelet
 (Decrease VS Increase) 0.311 0.118-0.818 0.018 0.293 0.107-0.799 0.017
D-dimer
 (Decrease VS Increase) 0.538 0.204-1.416 0.209    
 Male VS Female 0.207 0.059-0.724 0.014 0.195 0.042-0.914 0.038
 Age (≥62.5 vs. others) 1.937 0.716-5.240 0.193    
Substitution in exon 21
 (Yes vs. No) 1.008 0.355-2.867 0.988    
Deletion in exon 19
 (Yes vs. No) 1.150 0.443-2.987 0.774    
 Smoking(Yes vs. No) 2.931 1.112-7.730 0.030 0.695 0.199-2.422 0.568
Other treatment
 (Yes vs. No) 0.500 0.192-1.300 0.155    
Other diseases
 (Yes vs. No) 2.92 1.079-7.901 0.035 2.796 0.970-8.059 0.057
  1. OS overall survival, HR hazard ratio
\